Clinical trials still move like it’s 1995.
A decade of waiting, $1–2 billion spent, and a 90%+ failure rate on a clunky, fragmented system.
ARPA-H’s SURPASS program is rethinking the entire clinical trial model.
Adaptive platforms, predictive models, real-time analysis, and AI will make trials faster and cheaper so treatments reach patients years earlier.
Ready to stop waiting? Learn more about SURPASS ➡️https://t.co/yhVDUgns4c
The call should be opened in the next few weeks. Please send me a message if you have more questions - I will also update with more information as it goes.
Please retweet to increase the reach
The proposal should be three pages long, for around 50,000-500,000 for a period of 1-3 years. Companies and academic labs are both invited.
As someone in the field said - its time to move the needle and make some new progress.
The proposal should be three pages long, for around 50,000-500,000 for a period of 1-3 years. Companies and academic labs are both invited.
As someone in the field said - its time to move the needle and make some new progress.
1Establishing a method to generate delivery of secondary energy sources in vivo that reaches mitochondria and overcome barriers such as skin.
2Demonstrating that the combined work of 1+2 is able to synthesize a threshold of 10% synthetic ATP generation
1Establishing a method to generate delivery of secondary energy sources in vivo that reaches mitochondria and overcome barriers such as skin.
2Demonstrating that the combined work of 1+2 is able to synthesize a threshold of 10% synthetic ATP generation
Design of synthetically upgraded mitochondria with the ability to absorb an alternative power source to synthesize ATP independently of oxygen in a mammalian tissue (like the eye) . For example, inner membrane-integrated light-activated proton pumps
Design of synthetically upgraded mitochondria with the ability to absorb an alternative power source to synthesize ATP independently of oxygen in a mammalian tissue (like the eye) . For example, inner membrane-integrated light-activated proton pumps
ANNOUNCEMENT FOR POTENTIAL FUNDING
There is going to be (soon) a call for funding where you are encouraged to submit a proposal on upgrading our mitochondria (Mito 2.0) to be able to utilize a secondary energy source (e.g. photosynthetic mitochondria). These are potential points
ANNOUNCEMENT FOR POTENTIAL FUNDING
There is going to be (soon) a call for funding where you are encouraged to submit a proposal on upgrading our mitochondria (Mito 2.0) to be able to utilize a secondary energy source (e.g. photosynthetic mitochondria). These are potential points
Papers like this are why science remains endlessly exciting. This one made me feel the same wonder I felt at 15 when I first discovered science. || Homing pigeon navigation relies on superparamagnetic macrophages under overcast conditions | Science https://t.co/Rl3AlgF982
Mitochondria in our cells have their own genome. A new paper @nature shows it mutates sharply after age 60. Now rare, one day it might be common to receive a mito-transplant later in life 🧬 https://t.co/pEbhh9SWY2
Biology inspired breakthrough in robotics and a reminder that living systems still have so much to teach us. Great advances may come when engineers learn more from biology, and biologists learn more from engineering 🤝
I wrote something on aging, agency, and my why.
It starts with me being exactly the kind of teenager who wrote philosophy essays about Tolkien and ends with why I think aging shouldn’t be treated as fate
https://t.co/df5D7X7RMB
Martin Picard published one of the most important papers in modern biology in 2025.
Almost no one outside a small circle of researchers has heard of it.
The Energy Resistance Principle may explain disease, aging & energy crashes — from first principles.
Here’s the framework:🧵
REMOTE CONTROL MICE! A group from Seoul has just published in Cell that they’ve discovered a crazy-weird protein (Cyb5b) that can be used to turn on any gene when exposed to EMFs!
They used it to turn on OSK and extend the lifespan of a progeroid mouse. More to come on this…
Welcome to St. Servatius - where everyone is welcomed, unless, off course, you happen to be from Israel…
According to them, there isn’t such thing as Israel